A Phase II Trial of Ifosfamide in the Treatment of Advanced or Recurrent Squamous Cell Cancer of the Head and Neck

Abstracts/Posters/Presentations:

• Bandealy M, Hanna M, Arquette M, McClean J, Monaco F, Sandler A. A Phase II Trial of Ifosfamide in the Treatment of Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck. A Hoosier Oncology Group, The Walther Cancer Institute and Indiana UniversityL HN94-1. Accepted to the ASCO Annual Meeting May 17-20, 1997, Denver, CO.

Manuscripts/Articles:

• Sandler A, Saxman S, Bandealy M, Heilman D, Monaco F, McClean J, Arquette M. A Phase II Trial of Ifosfamide in the Treatment of Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck: Hoosier Oncology Group HN94-1. Am J Clin Oncol 21:195-197, 1998. See abstract.